Pediatric primary cutaneous anaplastic large cell lymphoma treated with brachytherapy.
brachytherapy
pediatric
primary cutaneous anaplastic large cell lymphoma
Journal
Pediatric dermatology
ISSN: 1525-1470
Titre abrégé: Pediatr Dermatol
Pays: United States
ID NLM: 8406799
Informations de publication
Date de publication:
May 2021
May 2021
Historique:
pubmed:
21
3
2021
medline:
8
7
2021
entrez:
20
3
2021
Statut:
ppublish
Résumé
Primary cutaneous anaplastic large cell lymphoma (PC-ALCL) is a CD30+ lymphoproliferative disorder that rarely occurs in children. Although there are currently no consensus guidelines for the treatment of cutaneous lymphoma in the pediatric population, the isolated form of PC-ALCL is typically managed by surgical excision or external beam radiation therapy. We report the case of a 6-year-old girl with primary cutaneous anaplastic large cell lymphoma that was treated with brachytherapy with no recurrence after 21 months of follow-up, suggesting that brachytherapy may be considered as a treatment for pediatric cutaneous large cell anaplastic lymphoma.
Substances chimiques
Ki-1 Antigen
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
712-713Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Goddard AL, Vleugels RA, LeBoeuf NR, et al. Palliative therapy for recalcitrant cutaneous T-cell lymphoma of the hands and feet with low-dose, high dose-rate brachytherapy. JAMA Dermatol. 2015;151(12):1354. https://doi.org/10.1001/jamadermatol.2015.3028
Kumar S, Pittaluga S, Raffeld M, Guerrera M, Seibel NL, Jaffe ES. Primary cutaneous CD30-positive anaplastic large cell lymphoma in childhood: report of 4 cases and review of the literature. Pediatr Dev Pathol. 2005;8(1):52-60. https://doi.org/10.1007/s10024-004-8087-6
Oschlies I, Lisfeld J, Lamant L, et al. ALK-positive anaplastic large cell lymphoma limited to the skin: clinical, histopathological and molecular analysis of 6 pediatric cases. A report from the ALCL99 study. Haematologica. 2013;98(1):50-56. https://doi.org/10.3324/haematol.2012.065664
Vergier B, Beylot-Barry M, Pulford K, et al. statistical evaluation of diagnostic and prognostic features of cd30+ cutaneous lymphoproliferative disorders: a clinicopathologic study of 65 cases. Am J Surg Pathol. 1998;22(10):1192-1202.
Otter SJ, Stewart AJ, Devlin PM. Modern brachytherapy. Hematol Oncol Clin North Am. 2019;33(6):1011-1025. https://doi.org/10.1016/j.hoc.2019.08.011